Twice-Daily PPI Leads to Higher EoE Remission Rates Twice-Daily PPI Leads to Higher EoE Remission Rates
The most optimal proton pump inhibitor regimen for histologic response in EoE may be a twice-daily moderate dose, with no additional benefits of a higher dose.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 2, 2024 Category: Allergy & Immunology Tags: Gastroenterology Source Type: news
Acid-Suppressive Medication and Antimicrobial Use in Infancy Associated with Food Allergy and Anaphylaxis
New research shows infants exposed to acid-suppressive medication had nearly a 6-fold increased risk of food allergy MILWAUKEE, Feb. 6, 2024 /PRNewswire-PRWeb/ -- Patients who were prescribed proton pump inhibitors (PPIs) in infancy demonstrated increased food allergy risk, according to... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 6, 2024 Category: Pharmaceuticals Tags: SVY TRI Source Type: news
How to Manage Heartburn Cost-Effectively After PPI Failure How to Manage Heartburn Cost-Effectively After PPI Failure
Endoscopy with ambulatory reflux monitoring was the most cost-effective approach to managing patients with heartburn in whom empirical proton pump inhibitor therapy failed.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 14, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Turmeric May Be as Effective as Omeprazole for Dyspepsia Turmeric May Be as Effective as Omeprazole for Dyspepsia
Curcumin, a compound found in the spice turmeric, may be as effective as the proton pump inhibitor omeprazole for treating indigestion.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 12, 2023 Category: Drugs & Pharmacology Tags: Internal Medicine News Source Type: news
PPIs Linked to Long-Term Infection in Kids PPIs Linked to Long-Term Infection in Kids
Experts said the new data show the importance of limiting use of this type of acid suppressant in children.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 29, 2023 Category: Drugs & Pharmacology Tags: Pediatrics News Source Type: news
Fast Heartburn Relief Without Deadly Drugs
Since gastroesophageal reflux disease (GERD) was first identified in the early 1930s, the number of people experiencing heartburn has increased substantially.
In fact, one study shows that in just 10 years, the number of people experiencing:1
Any GERD symptoms increased by 30%
Symptoms at least once a week increased by 47%
Severe GERD increased by 24%
While these numbers are concerning, I’ll admit they’re not surprising considering the typical American diet.
Our nutrition-less, grain-based diet of carbohydrates and starches has wrecked our health and made our bodies behave in ways nature never intended.
This has led ...
Source: Al Sears, MD Natural Remedies - August 28, 2023 Category: Complementary Medicine Authors: Jacob Tags: Health Heart Health Natural Cures Nutrition Source Type: news
Proton Pump Inhibitors Linked to Serious Infection Risk in Children
(MedPage Today) -- Proton pump inhibitors (PPIs) were strongly linked with serious infection risk among infants and young children in a large national study, suggesting caution in prescribing.
In more than one million children followed for approximately... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 14, 2023 Category: Gastroenterology Source Type: news
Cumulative PPI Use for More Than 4.4 Years Linked to Increased Risk for Dementia
THURSDAY, Aug. 10, 2023 -- Cumulative use of proton pump inhibitors (PPIs) for more than 4.4 years is associated with an increased risk for dementia, according to a study published online Aug. 9 in Neurology.
Carin Northuis, M.P.H., Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 10, 2023 Category: Pharmaceuticals Source Type: news
Dementia Risk Linked With Cumulative Heartburn Med Use, Analysis Suggests
(MedPage Today) -- Cumulative use of proton pump inhibitors (PPIs) -- drugs used to help control acid reflux and other gastrointestinal disorders -- upped the risk of dementia, an analysis of 5,700 older adults suggested.
Over a median follow... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - August 9, 2023 Category: Psychiatry Source Type: news
Acid reflux drugs taken by millions of Americans and Brits may raise the risk of DEMENTIA by up to a third, study suggests
Researchers from the University of Minnesota looked at drugs called proton pump inhibitors, or PPIs, which are taken for acid reflux and heartburn. They found a 33% higher risk of dementia. (Source: the Mail online | Health)
Source: the Mail online | Health - August 9, 2023 Category: Consumer Health News Source Type: news
PPIs May Curb Benefits of Palbociclib in Breast Cancer PPIs May Curb Benefits of Palbociclib in Breast Cancer
Concomitant use of a proton pump inhibitor with the CDK4/6 inhibitor palbociclib in women with advanced breast was associated with worse PFS and overall survival, a retrospective analysis shows.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 7, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
PPIs Linked to Worse Outcomes With Widely Used Breast Cancer Drug
(MedPage Today) -- Using proton pump inhibitors (PPIs) during treatment with palbociclib (Ibrance) was linked to higher risks of progression and death among patients with breast cancer, according to a retrospective cohort study from South Korea... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 22, 2023 Category: Gastroenterology Source Type: news
Some NSCLC Patients on ICI Therapy Fare Worse With Proton Pump Inhibitor Use
(MedPage Today) -- Proton pump inhibitor (PPI) use was independently associated with worse treatment outcomes in some patients with non-small cell lung cancer (NSCLC) on immune checkpoint inhibitor (ICI) therapy with pembrolizumab (Keytruda), according... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 11, 2023 Category: Hematology Source Type: news
No Link Between PPIs and Dementia in New Study No Link Between PPIs and Dementia in New Study
A study of older adults found no significant association between proton pump inhibitors (PPIs) or histamine-2 receptor antagonist (H2RA) use and dementia or cognitive decline.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 22, 2023 Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news
Scant Evidence for Proton Pump Inhibitor Role in Gastric Cancer Scant Evidence for Proton Pump Inhibitor Role in Gastric Cancer
Previous studies may not have accounted for the confounding role of the diseases for which the medications are prescribed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 13, 2023 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news
